Jacopo Giuliani

730 total citations
76 papers, 391 citations indexed

About

Jacopo Giuliani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jacopo Giuliani has authored 76 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Jacopo Giuliani's work include Colorectal Cancer Treatments and Studies (26 papers), Lung Cancer Treatments and Mutations (19 papers) and Gastric Cancer Management and Outcomes (17 papers). Jacopo Giuliani is often cited by papers focused on Colorectal Cancer Treatments and Studies (26 papers), Lung Cancer Treatments and Mutations (19 papers) and Gastric Cancer Management and Outcomes (17 papers). Jacopo Giuliani collaborates with scholars based in Italy, United States and Australia. Jacopo Giuliani's co-authors include Andrea Bonetti, Franco M. Muggia, Francesco Fiorica, Monica Indelli, Andrea Remo, Antonio Frassoldati, Carlotta Giorgi, Fabrizio Drudi, Sergio Sartori and Massimiliano Berretta and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Jacopo Giuliani

67 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacopo Giuliani Italy 12 206 194 67 65 48 76 391
Seiichiro Mitani Japan 11 258 1.3× 195 1.0× 102 1.5× 87 1.3× 38 0.8× 69 513
Emmanuel Zuber Switzerland 8 148 0.7× 209 1.1× 89 1.3× 98 1.5× 42 0.9× 15 458
Nikolaos A. Trikalinos United States 11 282 1.4× 100 0.5× 21 0.3× 86 1.3× 29 0.6× 62 482
Hans M. Westgeest Netherlands 13 150 0.7× 189 1.0× 23 0.3× 64 1.0× 94 2.0× 48 423
J.-L. Lee South Korea 8 137 0.7× 215 1.1× 23 0.3× 94 1.4× 91 1.9× 11 339
Rocco De Vivo Italy 14 166 0.8× 172 0.9× 19 0.3× 109 1.7× 33 0.7× 27 429
Carmela Caballero Belgium 10 164 0.8× 140 0.7× 17 0.3× 95 1.5× 84 1.8× 33 357
Alberto F. Sobrero Italy 15 578 2.8× 224 1.2× 34 0.5× 130 2.0× 126 2.6× 66 697
Igor Stukalin Canada 12 314 1.5× 278 1.4× 39 0.6× 105 1.6× 90 1.9× 47 541
Robert Díaz Beveridge Spain 11 172 0.8× 139 0.7× 11 0.2× 63 1.0× 48 1.0× 43 317

Countries citing papers authored by Jacopo Giuliani

Since Specialization
Citations

This map shows the geographic impact of Jacopo Giuliani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacopo Giuliani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacopo Giuliani more than expected).

Fields of papers citing papers by Jacopo Giuliani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacopo Giuliani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacopo Giuliani. The network helps show where Jacopo Giuliani may publish in the future.

Co-authorship network of co-authors of Jacopo Giuliani

This figure shows the co-authorship network connecting the top 25 collaborators of Jacopo Giuliani. A scholar is included among the top collaborators of Jacopo Giuliani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacopo Giuliani. Jacopo Giuliani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basile, Debora, et al.. (2025). The Current Role of Antiangiogenics in Colorectal Cancer. International Journal of Molecular Sciences. 26(23). 11605–11605.
2.
Fiorica, Francesco, Matteo Bauckneht, Jacopo Giuliani, et al.. (2025). Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints. Cancers. 17(13). 2247–2247.
3.
Fiorica, Francesco, Jacopo Giuliani, Antonella Franceschetto, et al.. (2024). Circulating DNA in Rectal Cancer to Unravel the Prognostic Potential for Radiation Oncologist. American Journal of Clinical Oncology. 48(2). 83–91. 1 indexed citations
4.
Giuliani, Jacopo, et al.. (2022). Long-term survivors of metastatic colorectal cancer treated with trifluridine/tipiracil. Recenti Progressi in Medicina. 113(6). 380–382. 2 indexed citations
6.
Fiorica, Francesco, María Teresa Colella, R. Taibi, et al.. (2020). Glioblastoma: Prognostic Factors and Predictive Response to Radio and Chemotherapy. Current Medicinal Chemistry. 27(17). 2814–2825. 1 indexed citations
7.
Giuliani, Jacopo & Andrea Bonetti. (2020). Trifluridine/Tipiracil in heavily pretreated metastatic gastric cancer. A perspective based on pharmacological costs. European Journal of Cancer. 138. 77–79.
8.
Giuliani, Jacopo & Andrea Bonetti. (2020). Cost-effectiveness of newer regimens for the prophylaxis of chemotherapy-induced nausea and vomiting: review of the literature and real-world data. Current Opinion in Oncology. 32(4). 269–273. 7 indexed citations
9.
Giuliani, Jacopo & Andrea Bonetti. (2019). Immunotherapy in first-line for advanced non-small cell lung cancer: <br>a cost-effective choice?. Recenti Progressi in Medicina. 110(3). 138–143. 11 indexed citations
10.
Giuliani, Jacopo & Andrea Bonetti. (2019). The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab. Anticancer Research. 39(7). 3971–3973. 29 indexed citations
11.
Giuliani, Jacopo & Andrea Bonetti. (2019). Financial Toxicity and Non-small Cell Lung Cancer Treatment: The Optimization in the Choice of Immune Check Point Inhibitors. Anticancer Research. 39(7). 3961–3965. 21 indexed citations
12.
Giuliani, Jacopo & Andrea Bonetti. (2019). The Onset of Grade ≥3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil. Anticancer Research. 39(7). 3967–3969. 7 indexed citations
13.
Giuliani, Jacopo & Andrea Bonetti. (2018). Anti-angiogenic agents in second-line treatment for metastatic colorectal cancer: the optimization of pharmacological costs. International Journal of Colorectal Disease. 33(10). 1487–1491. 3 indexed citations
14.
Giuliani, Jacopo & Andrea Bonetti. (2018). Cost-Effectiveness of Second-Line Treatments for Metastatic Renal-Cell Carcinoma. Clinical Genitourinary Cancer. 17(2). e258–e262. 2 indexed citations
16.
Giuliani, Jacopo & Andrea Bonetti. (2016). The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors. Clinical Lung Cancer. 17(6). 471–473. 1 indexed citations
17.
Bonetti, Andrea, Jacopo Giuliani, & Franco M. Muggia. (2015). Le terapie anti-tumorali a base di farmaci analoghi del platino. Recenti Progressi in Medicina. 106(12). 618–28. 1 indexed citations
18.
Giuliani, Jacopo & Benedetta Urbini. (2014). Spinal tuberculosis simulating metastatic malignancy: An unusual condition. Asian Pacific Journal of Tropical Medicine. 7(1). 83–84. 1 indexed citations
20.
Giuliani, Jacopo & Fabrizio Drudi. (2012). Immunotherapy and Targeted Therapies in Metastatic Renal Cell Carcinoma: Is There a Preferred Sequence?. Cancer Biotherapy and Radiopharmaceuticals. 27(8). 513–518. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026